Key facts
- This page summarizes Shefali Agarwal's Form 4 filing for Gritstone bio, Inc..
- 5 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 08 Apr 2025, 20:56.
Shefali Agarwal - 04 Apr 2025 Form 4 Insider Report for Gritstone bio, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 04 Apr 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Apr 2025, 20:56:52 UTC
- Prior SEC filing
- 20 Jun 2024
- Next SEC filing
- 30 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Vassiliki Economides, Attorney-in-Fact for Shefali Agarwal
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Shefali Agarwal filed Form 4 for Gritstone bio, Inc. on 08 Apr 2025.
Change
- Previous filing in this sequence was filed on 20 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GRTS
transaction
Derivative
Stock Option (Right to Buy)
Other
- Transaction value
- $0
- Shares
- -51,800
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 04 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 51,800
- Exercise price
- $2.19
- Footnotes
- F1, F2
GRTS
transaction
Derivative
Stock Option (Right to Buy)
Other
- Transaction value
- $0
- Shares
- -51,800
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 04 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 51,800
- Exercise price
- $0.7600
- Footnotes
- F1, F3
GRTS
transaction
Derivative
Stock Option (Right to Buy)
Other
- Transaction value
- $0
- Shares
- -38,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 04 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 38,000
- Exercise price
- $9.48
- Footnotes
- F1, F2
GRTS
transaction
Derivative
Stock Option (Right to Buy)
Other
- Transaction value
- $0
- Shares
- -937
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 04 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 937
- Exercise price
- $9.86
- Footnotes
- F1, F2
GRTS
transaction
Derivative
Stock Option (Right to Buy)
Other
- Transaction value
- $0
- Shares
- -19,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 04 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,000
- Exercise price
- $2.22
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Shefali Agarwal is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Pursuant to the Issuer's Second Modified Plan of Reorganization pursuant to Chapter 11 of the Bankruptcy Code, which was confirmed by the United States Bankruptcy Court for the District of Delaware on April 3, 2025 and became effective on April 4, 2025, each share of the Issuer's common stock and options to purchase the Issuer's common stock outstanding prior to the Issuer's emergence from bankruptcy were cancelled for no value.
Footnote F2
The options are fully vested.
Footnote F3
The option will vest and become exercisable on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through the applicable vesting date.